Topic Lifecycle: Dormant

This topic is currently dormant in the news cycle. It was last covered on Wednesday 11 November 2026 and has not appeared in recent broadcasts.

Coverage trend (last 30 days)

How much coverage this topic got from each channel over the past month.

On screen

Stills are sampled automatically at 60-second intervals. Where shown, the still is the nearest available frame from the relevant broadcast segment and is included to show what was on screen during that part of the broadcast. A still may not correspond to the exact second of a quoted phrase.

Channel 5, 5 News at Lunchtime, 9 September 2026
BBC One, BBC News at One including, 9 September 2026
ITV, ITV Lunchtime News, 9 September 2026
Channel 5, 5 News with Dan Walker, 9 September 2026
BBC One, BBC News, 9 September 2026
ITV, ITV Evening News, 9 September 2026
BBC One, BBC News, 10 September 2026
BBC One, BBC News and Weather, 10 September 2026
Sky News, Mornings with Jones and Melbourne, 27 September 2026
BBC One, BBC News at One including, 5 October 2026
ITV, ITV Lunchtime News, 6 October 2026
ITV, ITV Lunchtime News, 8 October 2026
BBC One, BBC News at One including, 4 November 2026
Channel 5, 5 News with Dan Walker, 4 November 2026
BBC One, BBC News, 4 November 2026
BBC Two, Newsnight, 11 November 2026

Recent stories

The latest story timelines linked to this topic, newest activity first.

Updated Wednesday 11 November 2026

Dormant

Terminal cancer MP Ashley Dalton criticises UK cancer outcomes and assisted dying bill

Labour MP Ashley Dalton, who has terminal cancer, tells BBC Two's Newsnight that UK cancer outcomes are unacceptable and explains her opposition to the assisted dying bill.

1 channel

Updated Wednesday 4 November 2026

Dormant

NHS trial to test GP blood tests for early abdominal cancers

More than 20,000 patients in England will be offered blood tests in an NHS trial aimed at helping GPs diagnose abdominal cancers earlier.

2 channels

Updated Friday 23 October 2026

Dormant

Personalised mRNA melanoma vaccine cuts recurrence or death risk by 42%

A large trial found that adding a personalised mRNA vaccine to immunotherapy cut the risk of melanoma returning or patients dying by 42% over two years.

1 channel

View all Cancer stories →

What was reported

A plain account of the latest full day of coverage, built from the channels that covered this topic.

No neutral summary available for this topic.

Timeline

Where this topic appeared. Cells show coverage time and are darker when there was more coverage.

Date Channel 5 BBC News BBC One BBC Two Channel 4 GB News ITV Sky News
Wednesday 11 November 2026 ——— 10m 12s 36.3% ————
Wednesday 4 November 2026 —— 1m 51s 1.8% —————
Friday 23 October 2026 —— 2m 39s 2.6% —————
Thursday 8 October 2026 —————— 2m 12s 2.6% —
Tuesday 6 October 2026 —————— 2m 49s 4.6% —
Monday 5 October 2026 —— 3m 38s 3.7% —————
Sunday 27 September 2026 ——————— 2m 57s 2.8%
Thursday 10 September 2026 —— 5m 43s 5.8% —————
Wednesday 9 September 2026 19s 1.1% ———————